ANRO vs. NGD

Last updated Jun 23, 2026

ANRO (Alto Neuroscience, Inc) and NGD (New Gold Inc.) are both stocks. ANRO operates in Biotechnology (Healthcare), while NGD operates in Gold (Basic Materials). At a 0.09 correlation, their price movements are largely independent.

Performance

ANRO vs. NGD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alto Neuroscience, Inc (ANRO) and New Gold Inc. (NGD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ANRO

• 1D: 0.84%
• 1M: 8.06%
• YTD: 28.82%
• 6M: 14.42%
• 1Y: 919.11%
• 3Y*: —
• 5Y*: —
• 10Y*: —

NGD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ANRO vs. NGD - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ANRO Alto Neuroscience, Inc	28.82%	320.80%	-80.77%
NGD New Gold Inc.	4.25%	251.21%	90.77%

Correlation

The correlation between ANRO and NGD is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (All Time) Calculated using the full available price history since Feb 2, 2024	0.09

Fundamentals

EPS ANRO : -$2.50 NGD : $1.61
Total Revenue (TTM) ANRO : $0.00 NGD : $1.46B
Gross Profit (TTM) ANRO : -$421.00K NGD : $758.26M
EBITDA (TTM) ANRO : -$74.36M NGD : $1.19B

Return for Risk

ANRO vs. NGD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANRO

ANRO Risk / Return Rank: 99
ANRO Sharpe Ratio Rank: 99
ANRO Sortino Ratio Rank: 98
ANRO Omega Ratio Rank: 98
ANRO Calmar Ratio Rank: 100
ANRO Martin Ratio Rank: 100

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANRO vs. NGD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alto Neuroscience, Inc (ANRO) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ANRO	NGD	Difference
Sharpe ratio: Return per unit of total volatility	7.23	—	—
Sortino ratio: Return per unit of downside risk	5.65	—	—
Omega ratio: Gain probability vs. loss probability	1.72	—	—
Calmar ratio: Return relative to maximum drawdown	27.15	—	—
Martin ratio: Return relative to average drawdown	70.91	—	—

Drawdowns

Drawdown Indicators

	ANRO	NGD	Difference
Max Drawdown Largest peak-to-trough decline	-91.82%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-34.20%	—	—
Current Drawdown Current decline from peak	-17.28%	—	—
Average Drawdown Average peak-to-trough decline	-53.30%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	13.07%	—	—

Volatility

Volatility by Period

	ANRO	NGD	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.19%	—	—
Volatility (6M) Calculated over the trailing 6-month period	54.92%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	128.77%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	115.37%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	115.37%	—	—

Dividends

ANRO vs. NGD - Dividend Comparison

Neither ANRO nor NGD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ANRO and NGD in my portfolio?

ANRO and NGD have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.